ALLIGATOR BIOSCIENCE NPV revenue breakdown overview

ALLIGATOR BIOSCIENCE NPV revenue for the last year amounted to 59.70 M SEK, the most of which — 57.77 M SEK — came from its highest performing source at the moment, Antibody-based Medicines, the year earlier bringing 58.11 M SEK. The greatest contribution to the revenue figure was made by Finland — last year it brought ALLIGATOR BIOSCIENCE NPV 57.76 M SEK, and the year before that — 58.11 M SEK.